Double-blinded randomized controlled trial of estrogen supplementation in adolescent girls who receive depot medroxyprogesterone acetate for contraception
- 1 January 2005
- journal article
- clinical trial
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 192 (1) , 42-47
- https://doi.org/10.1016/j.ajog.2004.07.041
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Bone mineral density in adolescent females using depot medroxyprogesterone acetateJournal of Pediatric and Adolescent Gynecology, 2004
- Bone mineral density in a cohort of adolescent women using depot medroxyprogesterone acetate for one to two yearsJournal of Adolescent Health, 2003
- A Randomized Controlled Trial of Estrogen Replacement Therapy in Long-Term Users of Depot Medroxyprogesterone AcetateJournal of Clinical Endocrinology & Metabolism, 2003
- Injectable Hormone Contraception and Bone Density: Results from a Prospective StudyEpidemiology, 2002
- Magnitude and variability of sequential estradiol and progesterone concentrations in women using depot medroxyprogesterone acetate for contraceptionFertility and Sterility, 2001
- A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptivesThe Journal of Pediatrics, 1996
- A dietary calcium rapid assessment method (RAM)Topics in Clinical Nutrition, 1994
- Recovery of bone density in women who stop using medroxyprogesterone acetateBMJ, 1994
- Clinical and Anthropometric Correlates of Bone Mineral Acquisition in Healthy Adolescent Girls*Journal of Clinical Endocrinology & Metabolism, 1991
- Bone density in women receiving depot medroxyprogesterone acetate for contraception.BMJ, 1991